1. WHO: Cancer, 2012. (accessed 9.10.12).
2. Iarc: Globocan 2008 fast stats. (accessed 9.10.12).
3. Optimal induction and post-remission therapy for AML in first remission;Rowe;Hematol. Am. Soc. Hematol. Educ. Program.,2009
4. Molecular genetic pathways as therapeutic targets in acute myeloid leukemia;Haferlach;Hematol. Am. Soc. Hematol. Educ. Program.,2008
5. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (edelfosine): molecular structure requirements, cellular uptake, and protection by bcl-2 and bcl-X(L);Mollinedo;Cancer Res.,1997